Aktiesnakken — Februar 2011
-
Blokerer vegf2
-
100% humant antistof
-
Et andet stof retter sig mod kemokine receptorer
-
Affitech bygger på en teknologi fra Breitling patentet
-
De har netop fået patent i EU
-
det må jeg så leve med.
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind